Literature DB >> 27170369

Neurologic Complications in Treated HIV-1 Infection.

Nisha S Bhatia1, Felicia C Chow2.   

Abstract

Effective combination antiretroviral therapy has transformed HIV infection into a chronic disease, with HIV-infected individuals living longer and reaching older age. Neurological disease remains common in treated HIV, however, due in part to ongoing inflammation and immune activation that persist in chronic infection. In this review, we highlight recent developments in our understanding of several clinically relevant neurologic complications that can occur in HIV infection despite treatment, including HIV-associated neurocognitive disorders, symptomatic CSF escape, cerebrovascular disease, and peripheral neuropathy.

Entities:  

Keywords:  HIV infection; Neurological complications; Viral suppression

Mesh:

Year:  2016        PMID: 27170369     DOI: 10.1007/s11910-016-0666-1

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  106 in total

1.  Sensory neuropathy in human immunodeficiency virus/acquired immunodeficiency syndrome patients: protease inhibitor-mediated neurotoxicity.

Authors:  Jacqueline A Pettersen; Gareth Jones; Catherine Worthington; Hartmut B Krentz; Oliver T Keppler; Ahmet Hoke; M John Gill; Christopher Power
Journal:  Ann Neurol       Date:  2006-05       Impact factor: 10.422

2.  Brain metabolism and cognitive impairment in HIV infection: a 3-T magnetic resonance spectroscopy study.

Authors:  Mona A Mohamed; Peter B Barker; Richard L Skolasky; Ola A Selnes; Richard T Moxley; Martin G Pomper; Ned C Sacktor
Journal:  Magn Reson Imaging       Date:  2010-08-04       Impact factor: 2.546

3.  Risk of spontaneous intracranial hemorrhage in HIV-infected individuals: a population-based cohort study.

Authors:  Madeleine Durand; Odile Sheehy; Jean-Guy Baril; Jacques LeLorier; Cécile L Tremblay
Journal:  J Stroke Cerebrovasc Dis       Date:  2012-05-02       Impact factor: 2.136

Review 4.  The neuropathogenesis of AIDS.

Authors:  Francisco González-Scarano; Julio Martín-García
Journal:  Nat Rev Immunol       Date:  2005-01       Impact factor: 53.106

5.  Peripheral neuropathy in HIV: prevalence and risk factors.

Authors:  Scott R Evans; Ronald J Ellis; Huichao Chen; Tzu-min Yeh; Anthony J Lee; Giovanni Schifitto; Kunling Wu; Ronald J Bosch; Justin C McArthur; David M Simpson; David B Clifford
Journal:  AIDS       Date:  2011-04-24       Impact factor: 4.177

6.  Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study.

Authors:  Barbara Hasse; Bruno Ledergerber; Hansjakob Furrer; Manuel Battegay; Bernhard Hirschel; Matthias Cavassini; Barbara Bertisch; Enos Bernasconi; Rainer Weber
Journal:  Clin Infect Dis       Date:  2011-10-13       Impact factor: 9.079

7.  NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: results of a 52-week open-label study.

Authors:  David M Simpson; Stephen Brown; Jeffrey K Tobias; Geertrui F Vanhove
Journal:  Clin J Pain       Date:  2014-02       Impact factor: 3.442

8.  Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.

Authors:  Scott Letendre; Jennifer Marquie-Beck; Edmund Capparelli; Brookie Best; David Clifford; Ann C Collier; Benjamin B Gelman; Justin C McArthur; J Allen McCutchan; Susan Morgello; David Simpson; Igor Grant; Ronald J Ellis
Journal:  Arch Neurol       Date:  2008-01

9.  Neuropsychological Impairment in Acute HIV and the Effect of Immediate Antiretroviral Therapy.

Authors:  Idil Kore; Jintanat Ananworanich; Victor Valcour; James L K Fletcher; Thep Chalermchai; Robert Paul; Jesse Reynolds; Somporn Tipsuk; Sasiwimol Ubolyam; Somprartthana Rattanamanee; Linda Jagodzinski; Jerome Kim; Serena Spudich
Journal:  J Acquir Immune Defic Syndr       Date:  2015-12-01       Impact factor: 3.731

10.  HIV infection and cardiovascular disease in women.

Authors:  Julie A Womack; Chung-Chou H Chang; Kaku A So-Armah; Charles Alcorn; Jason V Baker; Sheldon T Brown; Matthew Budoff; Adeel A Butt; Cynthia Gibert; Matthew Bidwell Goetz; John Gottdiener; Stephen Gottlieb; Amy C Justice; David Leaf; Kathleen McGinnis; David Rimland; Maria C Rodriguez-Barradas; Jason Sico; Melissa Skanderson; Hilary Tindle; Russell P Tracy; Alberta Warner; Matthew S Freiberg
Journal:  J Am Heart Assoc       Date:  2014-10-16       Impact factor: 5.501

View more
  12 in total

1.  HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue-Destructive Phenotype.

Authors:  Nancy P Y Chung; Xuemei Ou; K M Faisal Khan; Jacqueline Salit; Robert J Kaner; Ronald G Crystal
Journal:  Cell Rep       Date:  2017-05-09       Impact factor: 9.423

2.  Uncontrolled HIV and inflammation is associated with intracranial saccular aneurysm presence.

Authors:  Rachelle Dugue; Rebecca Schnall; Minghua Liu; Adam M Brickman; Marykay Pavol; Tiffany Porra; Jose Gutierrez
Journal:  AIDS       Date:  2022-02-18       Impact factor: 4.632

Review 3.  Genetics of HIV-associated sensory neuropathy and related pain in Africans.

Authors:  Huguette Gaelle Ngassa Mbenda; Antonia Wadley; Zane Lombard; Catherine Cherry; Patricia Price; Peter Kamerman
Journal:  J Neurovirol       Date:  2017-05-30       Impact factor: 2.643

4.  Lifetime marijuana and alcohol use, and cognitive dysfunction in people with human immunodeficiency virus infection.

Authors:  Sara A Lorkiewicz; Alicia S Ventura; Timothy C Heeren; Michael R Winter; Alexander Y Walley; Meg Sullivan; Jeffrey H Samet; Richard Saitz
Journal:  Subst Abus       Date:  2017-12-05       Impact factor: 3.716

5.  Antiretroviral Treatment with Efavirenz Disrupts the Blood-Brain Barrier Integrity and Increases Stroke Severity.

Authors:  Luc Bertrand; Levi Dygert; Michal Toborek
Journal:  Sci Rep       Date:  2016-12-23       Impact factor: 4.379

6.  Targeting the HIV-infected brain to improve ischemic stroke outcome.

Authors:  Luc Bertrand; Fannie Méroth; Marie Tournebize; Ana Rachel Leda; Enze Sun; Michal Toborek
Journal:  Nat Commun       Date:  2019-05-01       Impact factor: 14.919

7.  Peripheral neuropathy in HIV-infected and uninfected patients in Rakai, Uganda.

Authors:  Deanna Saylor; Gertrude Nakigozi; Noeline Nakasujja; Kevin Robertson; Ronald H Gray; Maria J Wawer; Ned Sacktor
Journal:  Neurology       Date:  2017-07-05       Impact factor: 9.910

8.  Cerebrovascular Disease Correlates With Longitudinal Brain Atrophy in Virally Suppressed Older People Living With HIV.

Authors:  Vishal Samboju; Yann Cobigo; Robert Paul; Georges Naasan; Madeline Hillis; Torie Tsuei; Shireen Javandel; Victor Valcour; Benedetta Milanini
Journal:  J Acquir Immune Defic Syndr       Date:  2021-08-01       Impact factor: 3.771

9.  Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection.

Authors:  A R Kallianpur; H Gittleman; S Letendre; R Ellis; J S Barnholtz-Sloan; W S Bush; R Heaton; D C Samuels; D R Franklin; D Rosario-Cookson; D B Clifford; A C Collier; B Gelman; C M Marra; J C McArthur; J A McCutchan; S Morgello; I Grant; D Simpson; J R Connor; T Hulgan
Journal:  Mol Neurobiol       Date:  2018-09-12       Impact factor: 5.682

10.  Pyrimidine 2,4-Diones in the Design of New HIV RT Inhibitors.

Authors:  Roberto Romeo; Daniela Iannazzo; Lucia Veltri; Bartolo Gabriele; Beatrice Macchi; Caterina Frezza; Francesca Marino-Merlo; Salvatore V Giofrè
Journal:  Molecules       Date:  2019-05-02       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.